Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
Scientific breakthrough: We can now halve the price of costly cancer drug
Taxol is one of the most commonly prescribed chemotherapy drugs for breast, ovarian, cervical and…
Incidence rates of some cancer types have risen in people under age 50
Researchers at the National Institutes of Health (NIH), USA, have completed a comprehensive analysis of…
GLP-1 receptor agonists show anti-cancer benefits beyond weight loss
New research presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14…
Algae microrobots deliver doxorubicin directly to lung tumours in mice
- Nano-immunotherapy developed to improve lung cancer treatment
- ASCO 2024: Telehealth as effective as in-person care for early palliative treatment in patients with advanced lung cancer
- ASCO 2024: Durvalumab following chemoradiotherapy improved survival in patients with limited-stage small-cell lung cancer
A new cancer treatment enters clinical trials in record time
This International Clinical Trials Day we are highlighting the first class research conducted at Peter MacCallum Cancer Centre from bench…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.